EBITDA Margin % is calculated as EBITDA divided by its Revenue. Stryker's EBITDA for the
three
months ended in Jun. 2023 was $1,227 Mil. Stryker's Revenue for the
three
months ended in Jun. 2023 was $4,996 Mil. Therefore, Stryker's EBITDA margin for the quarter that ended in Jun. 2023 was 24.56%.
Stryker EBITDA Margin % Historical Data
The historical data trend for Stryker's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Stryker Annual Data
Trend
Dec13
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
EBITDA Margin %
24.14
24.74
21.27
21.49
21.90
Stryker Quarterly Data
Sep18
Dec18
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
EBITDA Margin %
22.90
23.53
24.11
20.76
24.56
Competitive Comparison
For the Medical Devices subindustry, Stryker's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Stryker EBITDA Margin % Distribution
For the Medical Devices & Instruments industry and Healthcare sector, Stryker's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Stryker's EBITDA Margin % falls in comparison to its industry or sector. The grey bar indicates the EBITDA Margin %'s extreme value range as defined by GuruFocus.
Stryker EBITDA Margin % Calculation
EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.
Stryker's EBITDA Margin % for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Stryker (NYSE:SYK) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Stryker EBITDA Margin % Related Terms
Thank you for viewing the detailed overview of Stryker's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
0.14(0.05%) Volume: 1,315,973 11:08PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
SYK has been successfully added to your 
